Yu-Xi Liu Selected Research

Neoplasm Metastasis (Metastasis)

1/2023	Inhibition of STAT3 signaling contributes to the anti-melanoma effects of chrysoeriol.
1/2020	Activation of STAT3 is a key event in TLR4 signaling-mediated melanoma progression.
11/2019	MiR-let-7a/f-CCR7 signaling is involved in the anti-metastatic effects of an herbal formula comprising Sophorae Flos and Lonicerae Japonicae Flos in melanoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yu-Xi Liu Research Topics

Disease

10	Neoplasms (Cancer) 01/2023 - 01/2018
8	Melanoma (Melanoma, Malignant) 01/2023 - 12/2017
3	Neoplasm Metastasis (Metastasis) 01/2023 - 11/2019
3	Endometrial Neoplasms (Endometrial Cancer) 11/2022 - 01/2022
2	Inflammation (Inflammations) 01/2023 - 03/2020
2	Seizures (Absence Seizure) 11/2021 - 04/2008
1	Primary Ovarian Insufficiency 01/2023
1	Breast Neoplasms (Breast Cancer) 01/2023
1	Multiple Myeloma 01/2023
1	Lung Neoplasms (Lung Cancer) 01/2023
1	Hepatocellular Carcinoma (Hepatoma) 01/2022
1	Colorectal Neoplasms (Colorectal Cancer) 01/2022
1	Liver Failure 01/2022
1	Microsatellite Instability 01/2022
1	Partial Epilepsies (Epilepsy, Partial) 11/2021
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021
1	Body Weight (Weight, Body) 11/2020
1	Rheumatoid Arthritis 05/2020
1	Reperfusion Injury 03/2020
1	Edema (Dropsy) 03/2020
1	Experimental Melanoma 03/2020
1	Brain Ischemia (Cerebral Ischemia) 03/2020
1	Liver Neoplasms (Liver Cancer) 01/2020
1	Carcinogenesis 01/2018
1	Epilepsy (Aura) 04/2008

Drug/Important Bio-Agent (IBA)

4	Long Noncoding RNAIBA 01/2023 - 01/2022
3	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2023 - 01/2020
3	CytokinesIBA 01/2022 - 01/2018
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2019
2	chrysoeriolIBA 01/2023 - 03/2020
2	CateninsIBA 06/2022 - 10/2020
2	Messenger RNA (mRNA)IBA 01/2022 - 01/2019
2	dioscinIBA 01/2022 - 03/2020
2	MicroRNAs (MicroRNA)IBA 10/2020 - 11/2019
2	LigandsIBA 05/2020 - 01/2020
1	FlavonoidsIBA 01/2023
1	5-ethynyl-2'-deoxyuridineIBA 01/2023
1	Caspase 9IBA 01/2023
1	FITC-annexin A5IBA 01/2023
1	Oncogene Proteins (Oncogene Protein)IBA 01/2023
1	Protein Kinases (Protein Kinase)IBA 01/2023
1	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 01/2023
1	Conditioned Culture MediaIBA 01/2022
1	glycocalicinIBA 01/2022
1	trienomycin AIBA 01/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	Rifabutin (Ansamycin)FDA Link 01/2021
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2021
1	Alanine Transaminase (SGPT)IBA 11/2020
1	Alkaline PhosphataseIBA 11/2020
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 11/2020
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 11/2020
1	si-jun-zi-tangIBA 10/2020
1	AdamantaneIBA 04/2020
1	CyclodextrinsIBA 04/2020
1	Hyaluronic Acid (Hyaluronan)IBA 04/2020
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2020
1	Sirolimus (Rapamycin)FDA Link 01/2020
1	Toll-Like Receptor 4IBA 01/2020
1	schizandrin BIBA 01/2020
1	LignansIBA 01/2020
1	RNA (Ribonucleic Acid)IBA 11/2019
1	CC ChemokinesIBA 11/2019
1	Thioredoxin-Disulfide ReductaseIBA 01/2018
1	ThioredoxinsIBA 01/2018
1	butaselenIBA 01/2018
1	B7-H1 AntigenIBA 01/2018
1	p38 Mitogen-Activated Protein KinasesIBA 12/2017
1	Aurora Kinase AIBA 12/2017
1	Cyclin B1IBA 12/2017
1	MLN 8237IBA 12/2017
1	Hydrocortisone (Cortisol)FDA LinkGeneric 04/2008
1	BemegrideIBA 04/2008
1	Adrenocorticotropic Hormone (ACTH)FDA Link 04/2008

Therapy/Procedure

3	Chinese Traditional Medicine (Traditional Chinese Medicine) 06/2022 - 01/2019
2	Therapeutics 11/2021 - 10/2020
1	Hepatectomy 01/2022
1	Oral Administration 11/2020